Literature DB >> 7288601

Aberrant Pharmacokinetics of harmol in the perfused rat liver preparation: sulfate and glucuronide conjugations.

K S Pang, H Koster, I C Halsema, E Scholtens, G J Mulder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7288601

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  7 in total

1.  A comparative investigation of hepatic clearance models: predictions of metabolite formation and elimination.

Authors:  M V St-Pierre; P I Lee; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1992-04

2.  Competition between two enzymes for substrate removal in liver: modulating effects due to substrate recruitment of hepatocyte activity.

Authors:  M E Morris; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1987-10

3.  Primary, secondary, and tertiary metabolite kinetics.

Authors:  M V St-Pierre; X Xu; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1988-10

Review 4.  A review of metabolite kinetics.

Authors:  K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1985-12

5.  Expression of a high-affinity form of UDP-glucuronosyltransferase in human foetal liver cells in culture on exposure to mercuric chloride.

Authors:  T M Tan; K P Wong; K H Sit
Journal:  Biochem J       Date:  1991-08-15       Impact factor: 3.857

6.  Pharmacokinetics of tetrahydronorharmane (tetrahydro-beta-carboline) in rats.

Authors:  B Greiner; C Fähndrich; S Strauss; H Rommelspacher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-03       Impact factor: 3.000

7.  Competing pathways in drug metabolism. II. An identical, anterior enzymic distribution for 2- and 5-sulfoconjugation and a posterior localization for 5-glucuronidation of gentisamide in the rat liver.

Authors:  M E Morris; V Yuen; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1988-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.